FUSN
Price
$21.55
Change
-$0.00 (-0.00%)
Updated
Sep 20 closing price
SXTP
Price
$1.35
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
68 days until earnings call
Ad is loading...

FUSN vs SXTP

Header iconFUSN vs SXTP Comparison
Open Charts FUSN vs SXTPBanner chart's image
Fusion Pharmaceuticals
Price$21.55
Change-$0.00 (-0.00%)
Volume$6.08M
CapitalizationN/A
60 Degrees Pharmaceuticals
Price$1.35
Change-$0.00 (-0.00%)
Volume$43.7K
CapitalizationN/A
View a ticker or compare two or three
FUSN vs SXTP Comparison Chart
Loading...
SXTP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
FUSN vs. SXTP commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FUSN is a Buy and SXTP is a Hold.

COMPARISON
Comparison
Sep 21, 2024
Stock price -- (FUSN: $21.55 vs. SXTP: $1.41)
Brand notoriety: FUSN and SXTP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FUSN: 100% vs. SXTP: 6%
Market capitalization -- FUSN: $1.83B vs. SXTP: $2.42M
FUSN [@Biotechnology] is valued at $1.83B. SXTP’s [@Biotechnology] market capitalization is $2.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $595.57B to $0. The average market capitalization across the [@Biotechnology] industry is $2.99B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FUSN’s FA Score shows that 0 FA rating(s) are green whileSXTP’s FA Score has 1 green FA rating(s).

  • FUSN’s FA Score: 0 green, 5 red.
  • SXTP’s FA Score: 1 green, 4 red.
According to our system of comparison, both FUSN and SXTP are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SXTP’s TA Score shows that 3 TA indicator(s) are bullish.

  • SXTP’s TA Score: 3 bullish, 3 bearish.

Price Growth

FUSN (@Biotechnology) experienced а 0.00% price change this week, while SXTP (@Biotechnology) price change was +8.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.40%. For the same industry, the average monthly price growth was +1.46%, and the average quarterly price growth was -0.90%.

Reported Earning Dates

FUSN is expected to report earnings on Aug 06, 2024.

SXTP is expected to report earnings on Nov 27, 2024.

Industries' Descriptions

@Biotechnology (+0.40% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FUSN($1.83B) has a higher market cap than SXTP($2.42M). FUSN YTD gains are higher at: 124.246 vs. SXTP (-88.480).
FUSNSXTPFUSN / SXTP
Capitalization1.83B2.42M75,650%
EBITDAN/A-1.49M-
Gain YTD124.246-88.480-140%
P/E RatioN/AN/A-
RevenueN/A418K-
Total CashN/A1.58M-
Total DebtN/A157K-
TECHNICAL ANALYSIS
Technical Analysis
SXTP
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 4 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
SXTP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WINT3.320.12
+3.75%
Windtree Therapeutics
GAIN13.450.45
+3.46%
Gladstone Investment Corp
X36.780.55
+1.52%
United States Steel Corp
TOWN34.130.22
+0.65%
TowneBank
BATL3.05N/A
N/A
Battalion Oil Corp

FUSN and

Correlation & Price change

A.I.dvisor indicates that over the last year, FUSN has been closely correlated with PIRS. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if FUSN jumps, then PIRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FUSN
1D Price
Change %
FUSN100%
N/A
PIRS - FUSN
67%
Closely correlated
-2.42%
QTTB - FUSN
65%
Loosely correlated
-3.19%
CDTX - FUSN
65%
Loosely correlated
-0.09%
RNAC - FUSN
65%
Loosely correlated
-6.01%
KPRX - FUSN
65%
Loosely correlated
+4.62%
More

SXTP and

Correlation & Price change

A.I.dvisor tells us that SXTP and RVNC have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SXTP and RVNC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SXTP
1D Price
Change %
SXTP100%
-2.08%
RVNC - SXTP
25%
Poorly correlated
+0.42%
FUSN - SXTP
22%
Poorly correlated
N/A
VRAX - SXTP
22%
Poorly correlated
-6.27%
APGE - SXTP
21%
Poorly correlated
+5.33%
OABI - SXTP
20%
Poorly correlated
+0.66%
More